Quick10K

⚲

Green Plains Partners

Filings

10-Q	2021-03-31	Filed 2021-05-04
10-K	2020-12-31	Filed 2021-02-16
10-Q	2020-09-30	Filed 2020-11-06
10-Q	2020-06-30	Filed 2020-08-05
10-Q	2020-03-31	Filed 2020-05-06
10-K	2019-12-31	Filed 2020-02-20
10-Q	2019-09-30	Filed 2019-11-07
10-Q	2019-06-30	Filed 2019-08-06
10-Q	2019-03-31	Filed 2019-05-09
10-K	2018-12-31	Filed 2019-02-20
10-Q	2018-09-30	Filed 2018-11-09
10-Q	2018-06-30	Filed 2018-08-02
10-Q	2018-03-31	Filed 2018-05-07
10-K	2017-12-31	Filed 2018-02-14
10-Q	2017-09-30	Filed 2017-11-02
10-Q	2017-06-30	Filed 2017-08-03
10-Q	2017-03-31	Filed 2017-05-04
10-K	2016-12-31	Filed 2017-02-22
10-Q	2016-09-30	Filed 2016-11-03
10-Q	2016-06-30	Filed 2016-08-03
10-Q	2016-03-31	Filed 2016-05-05
10-K	2015-12-31	Filed 2016-02-18
10-Q	2015-09-30	Filed 2015-11-05
10-Q	2015-06-30	Filed 2015-08-12

Reports

8-K	2021-02-09
8-K	2021-01-25
8-K	2021-01-21
8-K	2020-12-28
8-K	2020-12-14
8-K	2020-11-04
8-K	2020-10-15
8-K	2020-08-03
8-K	2020-07-16
8-K	2020-06-04
8-K	2020-05-04
8-K	2020-04-16
8-K	2020-03-18
8-K	2020-02-10
8-K	2020-01-16
8-K	2019-11-05
8-K	2019-10-17
8-K	2019-08-05
8-K	2019-07-18
8-K	2019-05-08
8-K	2019-05-08
8-K	2019-04-18
8-K	2019-02-11
8-K	2019-01-17
8-K	2018-11-30
8-K	2018-11-15
8-K	2018-11-07
8-K	2018-10-18
8-K	2018-10-15
8-K	2018-10-10
8-K	2018-08-01
8-K	2018-08-01
8-K	2018-07-19
8-K	2018-07-16
8-K	2018-05-07
8-K	2018-04-19
8-K	2018-03-19
8-K	2018-02-16
8-K	2018-02-07
8-K	2018-01-18

Green Plains Partners Financials

GPP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	4,541	18,234	16,385	5,626	2,764	1,325	622	893	2,939	253	502	588	268	432	569	304	269	990
Accounts Receivable	489	348	566	905	1,137	517	1,513	958	799	812	2,640	811	1,223	732	1,460	2,277	1,090	697
Inventory
PP&E	29,812	54,298	55,094	41,357	40,412	51,986	74,900	50,156	50,073	49,630	77,282	48,339	47,241	46,156	69,176	39,926	38,822	38,052
Assets	44,398	93,317	89,551	81,198	78,775	88,935	93,776	93,303	90,627	92,797	92,268	96,890	92,191	89,311	81,144	121,400	123,178	119,758
Accounts Payable	347	10,052	9,699	4,411	4,738	4,849	4,280	8,333	6,759	8,690	5,854	10,675	6,353	7,534	2,501	4,697	5,774	6,707
Long-Term Debt	8,100	8,100	8,100	59,100	55,100	140,100	137,100	134,600	136,000	137,100	135,000	137,100	137,000	136,100	142,100	143,037	140,249	140,062
Liabilities	10,855	27,034	24,040	72,592	69,285	155,975	157,942	156,386	154,843	157,112	155,114	161,610	158,623	156,711	153,598	194,796	197,055	194,696
Stockholders' Equity	33,286	66,283	65,511	8,606	9,490	-67,040	-64,166	-63,083	-64,216	-64,315	-62,846	-64,720	-66,432	-67,400	-72,454	-73,396	-73,877	-74,938


Income Statement ($'000)	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	3,445	21,410	22,686	23,789	25,493	26,205	28,285	27,229	25,132	26,449	28,250	25,885	25,840	25,770	23,253	21,087	20,825	20,154
Cost of Revenue
Gross Profit
R&D
SG&A	403	1,032	1,483	1,209	1,051	1,395	769	1,212	1,124	922		1,401	1,179	1,109		1,117	988	949
Tax	343	-4,788	-10	176	79	52	-80	95	48	43	0	71	53	5	31	126	47	45
Net Income	578	10,879	12,130	12,182	13,982	14,199	16,442	14,977	13,863	14,466	16,339	13,372	13,722	14,451		10,248	10,709	10,132


Cash Flow ($'000)	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		1,381	11,569	13,699	14,517	17,983	15,996	16,724	16,055	12,884	18,391	14,689	16,570	16,698		10,004	13,952	12,203
Cash Investing		-308	-473	-62,399	-244	-90,136	-70			-2,065	-966	-1,212	-1,296	-139				-8
Cash Financing		12,620	-12,945	37,941	-17,135	70,714	-16,629	-16,453	-12,878	-13,505	-17,176	-13,391	-15,594	-16,395		-10,269	-14,069	-11,474